Pharmacogenomics (PGx) Testing for Military Readiness Pilot
ID: MTEC-25-PGxType: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE - OTHER; EXPERIMENTAL DEVELOPMENT (AN43)

Original Source

https://sam.gov/opp/bcf747ec74904a73969865425913fa1a/view
Timeline
    Description

    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for a pilot program focused on pharmacogenomics (PGx) testing to enhance military readiness and healthcare delivery for Active-Duty service members. The initiative aims to establish standardized processes for routine PGx testing within the Military Health System (MHS), leveraging electronic health record (EHR) data to improve clinical decision-making and treatment outcomes. This program is critical for optimizing medication safety and efficacy, ultimately preventing adverse drug reactions and improving overall health conditions for military personnel. Interested parties should contact Dr. Lauren Palestrini at lauren.palestrini@mtec-sc.org, with a funding availability of $2.2 million and a project duration of up to 36 months. The Request for Project Proposals (RPP) is expected to be released soon, with a proposal preparation period of approximately 30 days.

    Point(s) of Contact
    Dr. Lauren Palestrini
    lauren.palestrini@mtec-sc.org.
    Files
    Title
    Posted
    MTEC-25-PGX_Pre-Announcement.pdf
    The Medical Technology Enterprise Consortium (MTEC) has issued a pre-announcement for a Request for Project Proposals (RPP) aimed at launching a pilot program on pharmacogenomics (PGx) testing within the Military Health System (MHS). This initiative responds to the FY24 DoD Appropriations Act and seeks to enhance medical treatment for Active-Duty service members (ADSMs) and ultimately improve military readiness. The pilot program will demonstrate standardized processes for routine PGx testing, leveraging electronic health record (EHR) data to inform clinical decision-making and improve healthcare delivery. Key objectives include fostering collaboration with Military Treatment Facilities, integrating PGx into clinical care, and evaluating treatment outcomes relating to drug efficacy and safety. Proposals must be submitted by a qualified team that includes clinical pharmacists experienced in PGx and compliant with government data access requirements. The funding availability for the program stands at $2.2 million, with a project duration of up to 36 months for successful proposals. MTEC's overarching mission is to facilitate advanced medical technology solutions for military personnel, ensuring they receive optimized healthcare. This pilot program highlights the Department of Defense’s commitment to employing precision medicine in enhancing the effectiveness and safety of medical interventions for its service members.
    Lifecycle
    Title
    Type
    Pharmacogenomics (PGx) Testing for Military Readiness Pilot
    Currently viewing
    Presolicitation
    Similar Opportunities
    Health Care Delivery Solutions (HCDS) Electronic Health Record Follow-on (MHS GENESIS)
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking industry input for the Health Care Delivery Solutions (HCDS) Electronic Health Record (EHR) Follow-on (MHS GENESIS) procurement. This initiative aims to modernize the DoD's healthcare management system by enhancing interoperability, optimizing patient care, and leveraging commercial technology advancements while ensuring efficient integration with the Department of Veterans Affairs (VA). The procurement process is critical for maintaining a robust electronic health record system that serves approximately 9.6 million beneficiaries and 194,000 users. Interested parties are encouraged to submit their responses to the Request for Information (RFI) by November 17, 2025, and can direct inquiries to Sonya Edom at sonya.m.edom.civ@health.mil or Gabriela Hurte at gabriela.y.hurte.civ@health.mil. The anticipated timeline includes a draft RFP in Q1 FY26 and contract awards by Q4 FY26.
    TRICARE Pharmacy Program RFI
    Dept Of Defense
    The Defense Health Agency (DHA) is conducting a Request For Information (RFI) for its next-generation TRICARE Pharmacy Program (TPharm) contract, aimed at gathering industry feedback to inform the program's requirements and design. The RFI focuses on key areas such as pharmacy benefit administration, mail order pharmacy fulfillment, enhanced care programs, and operational barriers affecting vendor participation in federal pharmacy contracts. This program is crucial as it serves over 9.6 million beneficiaries and integrates various pharmacy services, including retail and mail order options. Interested parties are encouraged to submit their responses via email to dha.buckley.ad-spt-cae.mbx.tpharm6@health.mil by January 30, 2026, at 12:00 pm MST, as the DHA seeks to utilize this information for market research purposes.
    Defense Health Agency Data Governance Transforming the Data Landscape: A Strategic Imperative for Modern Healthcare in Support of Military Readiness
    Dept Of Defense
    The Defense Health Agency (DHA) is seeking proposals from qualified small businesses to provide contractor support for advancing enterprise data readiness and governance within the Military Health System. The primary objectives include developing a comprehensive baseline data inventory, establishing a centralized metadata repository, conducting an Analysis of Alternatives for an enterprise data catalog, and implementing automated metadata harvesting tools to enhance data accessibility and usability. This initiative is crucial for improving decision-making and operational efficiency in military healthcare, with a total contract value of $34 million and a performance period from January 30, 2026, to January 29, 2027, with options for additional 12-month periods. Interested parties should direct inquiries to Linda M. Walker or Andrea V. Rivas via email, and proposals must be submitted electronically by January 9, 2026.
    Pharmacy Data Warehouse
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking to extend the contract for the Pharmacy Data Warehouse (PDW) managed by General Dynamics Information Technology, Inc. (GDIT) for an additional 16 months, until July 24, 2024. This bridge action is necessary to maintain the continuity of services related to the management of TRICARE pharmacy transaction data, which is critical for ensuring patient safety and supporting various analyses related to drug utilization and fraud prevention. The extension is vital to avoid disruptions that could impact the Federal Pricing Refund Program and the Military Health System's readiness tools, as well as to fulfill congressional reporting requirements. Interested parties can contact Viktoria Reed at viktoria.s.reed.civ@health.mil or call 303-676-3648 for further information.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense (DoD) is issuing a Request for Quotation (RFQ) for pharmaceutical agents to establish Blanket Purchase Agreements (BPAs) and an Additional Discount Program (ADP) as part of its Uniform Formulary for the Military Health System. This procurement aims to secure effective and cost-efficient pharmaceutical agents, including newly approved drugs for various therapeutic classes, which will be evaluated by the Pharmacy and Therapeutics (P&T) Committee for inclusion in the formulary. The selected agents will play a crucial role in providing essential medications to military personnel and their families, ensuring access to high-quality healthcare. Interested manufacturers must submit their quotes by January 5, 2026, with a pre-quotation teleconference scheduled for December 17, 2025; for further inquiries, contact Tracy Banks at tracy.e.banks2.civ@health.mil or Julia Trang at julia.n.trang.civ@health.mil.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
    MTEC-26-01-BloodBag Request for Project Proposals Pre-Announcement
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for the manufacturing of single blood donor collection and storage bags within the Continental United States (CONUS). This initiative aims to address the critical shortage of blood storage bags, particularly for use in forward military operations, by establishing domestic manufacturing capabilities to ensure rapid production in times of need. The selected proposals will focus on producing blood bags that meet specific FDA and military standards, with an expected funding availability of up to $4 million for initial awards ranging from $1 to $3 million, and a performance period not exceeding 42 months. Interested parties should contact Dr. Chuck Hutti at chuck.hutti@ati.org for further inquiries and must be members of the Medical Technology Enterprise Consortium (MTEC) to submit proposals, which are anticipated to be released shortly.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotes for a Blanket Purchase Agreement (BPA) and an Additional Discount Program (ADP) for pharmaceutical agents to be included in the DoD Uniform Formulary (UF). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on oncological agents for myelofibrosis and antihemophilic agents, with evaluations based on clinical and cost-effectiveness. Interested vendors must submit their quotes by January 16, 2026, with a pre-quotation teleconference scheduled for November 20, 2025. For further inquiries, contact Tracy Banks at tracy.e.banks2.civ@health.mil or Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil.
    Customer Care Prototyping - Commercial Solution Opening (Notice of Availability)
    Dept Of Defense
    The Defense Health Agency (DHA) is seeking innovative solutions through its "Customer Care Prototyping 2025-2026" initiative, aimed at enhancing customer care within the Military Health System (MHS). This opportunity invites prototype projects under the authority of 10 U.S.C. § 4022, focusing on developing a foundational platform that prioritizes agile development, self-service support, and data-driven insights to improve mission effectiveness and customer sentiment while reducing costs. Interested vendors should monitor SAM for updates regarding submission instructions and evaluation criteria, with the first "Season Notice" expected in Q1 FY26. For inquiries, contact Gabriela Hurte at gabriela.y.hurte.civ@health.mil or Sonya Edom at sonya.m.edom.civ@health.mil.
    Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army, is seeking collaboration with qualified entities for the Generative Unconstrained Intelligence Drug Engineering (GUIDE) program, aimed at accelerating the development of medical countermeasures for warfighters. This initiative involves an integrated computational and experimental platform that leverages advanced simulation and machine learning to enhance the discovery and design of biological products and small molecule drugs, ensuring safety, efficacy, and manufacturability. The GUIDE program is critical for improving preparedness against diverse threats and is executed under a Participant Basic Agreement (PBA), with interested parties encouraged to demonstrate their technical relevance by contacting the primary points of contact, Joseph McCaffery and Keith Pereira, via email. Participation is contingent upon registration in the System for Award Management (SAM) database, and the government emphasizes that this announcement is for planning purposes only, with no commitment to award contracts at this stage.